![PDF) Prognostic value of serum C-Reactive Protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not Carcinoembryonic Antigen (CEA) in surgically treated patients with non-small cell lung cancer PDF) Prognostic value of serum C-Reactive Protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not Carcinoembryonic Antigen (CEA) in surgically treated patients with non-small cell lung cancer](https://www.researchgate.net/profile/Piotr-Rudzinski/publication/264868000/figure/tbl1/AS:392208290205701@1470521151187/Cyfra-21-1-CEA-and-CRP-according-to-the-pathological-stage-of-the-disease-in-50-NSCLC_Q320.jpg)
PDF) Prognostic value of serum C-Reactive Protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not Carcinoembryonic Antigen (CEA) in surgically treated patients with non-small cell lung cancer
![EPMA World Congress: Traditional Forum in Predictive, Preventive and Personalised Medicine for Multi-Professional Consideration and Consolidation | SpringerLink EPMA World Congress: Traditional Forum in Predictive, Preventive and Personalised Medicine for Multi-Professional Consideration and Consolidation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13167-017-0108-4/MediaObjects/13167_2017_108_Figs_HTML.gif)
EPMA World Congress: Traditional Forum in Predictive, Preventive and Personalised Medicine for Multi-Professional Consideration and Consolidation | SpringerLink
![Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - The Lancet Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - The Lancet](https://www.thelancet.com/cms/asset/e52a65a7-8607-4967-8701-3c310d11632e/gr1.jpg)
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - The Lancet
![Maternal exposure to ambient black carbon particles and their presence in maternal and fetal circulation and organs: an analysis of two independent population-based observational studies - The Lancet Planetary Health Maternal exposure to ambient black carbon particles and their presence in maternal and fetal circulation and organs: an analysis of two independent population-based observational studies - The Lancet Planetary Health](https://www.thelancet.com/cms/attachment/edc01f82-3c52-4fb2-8f0f-2ebfe54027a7/gr1_lrg.jpg)
Maternal exposure to ambient black carbon particles and their presence in maternal and fetal circulation and organs: an analysis of two independent population-based observational studies - The Lancet Planetary Health
![Medicina | Free Full-Text | Non-IgE Mediated Hypersensitivity to Food Products or Food Intolerance—Problems of Appropriate Diagnostics | HTML Medicina | Free Full-Text | Non-IgE Mediated Hypersensitivity to Food Products or Food Intolerance—Problems of Appropriate Diagnostics | HTML](https://www.mdpi.com/medicina/medicina-57-01245/article_deploy/html/images/medicina-57-01245-g001.png)